resveratrol has been researched along with Bright Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayakawa, K; Hiramatsu, N; Kasai, A; Kitamura, M; Meng, Y; Uchida, Y; Watanabe, S; Yamauchi, K; Yamazaki, H; Yao, J | 1 |
| Miura, Y; Nihei, T; Yagasaki, K | 1 |
2 other study(ies) available for resveratrol and Bright Disease
| Article | Year |
|---|---|
Enhancement of NF-kappaB activity by resveratrol in cytokine-exposed mesangial cells.
Topics: Alkaline Phosphatase; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Line; Cell Line, Tumor; Chemokine CCL2; Cytokines; Gene Expression Regulation; Glomerulonephritis; I-kappa B Proteins; Intercellular Adhesion Molecule-1; Kidney Glomerulus; Male; NF-kappa B; NF-KappaB Inhibitor alpha; Nitric Oxide; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Tumor Necrosis Factor-alpha | 2005 |
Inhibitory effect of resveratrol on proteinuria, hypoalbuminemia and hyperlipidemia in nephritic rats.
Topics: Administration, Oral; Albumins; Animals; Anti-Inflammatory Agents, Non-Steroidal; Basement Membrane; Blood Urea Nitrogen; Body Weight; Cholesterol; Disease Models, Animal; Eating; Glomerulonephritis; Hyperlipidemias; Hypoproteinemia; Kidney; Kidney Glomerulus; Liver; Male; Organ Size; Proteinuria; Rabbits; Rats; Rats, Wistar; Resveratrol; Stilbenes; Triglycerides | 2001 |